Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cell & gene therapy

Research Field

FDA Quackdown

| James Strachan |

Regulators step in to stop stem cell clinics from marketing unproven therapies.

Research Field

Fresher and CRISPR

|

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

Research Field

The Best Treatment

| Ruth Steer |

Is gene therapy the answer to an untreatable form of macular degeneration?

Research Field

The Secret is the Secretions

| Nicolas Sohl |

Stem cells hold great promise, but is it the cells we really need?

Research Field

Pulling Back the Curtain: Combinatorial Screening

|

What are the realities of translating exciting cell and gene therapy research into something more tangible?

Research Field

Image of the Month

|

Stem cells with a seasonal theme.

Research Field

Believe in RNAi

| Geert Cauwenbergh |

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender

Research Field

Recognizing Friend from Foe

| Werner Cautreels |

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.

Tools & Techniques

Babies’ Breath

| Jegen Kandasamy |

Research reveals a potential noninvasive predictor of bronchopulmonary dysplasia risk in preterm infants

Research Field

Image of the Month

|

A scanning electron micrograph of porous poly lactic-co-glycolic acid (PLGA) microparticles.


Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register